[Clinico-pathological changes after intravenous administration of endotoxin in the horse]
Related Experiment Video
Updated: Oct 14, 2026

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
1Departement Geneeskunde, Fakulteit Veeartsenykunde, Universiteit van Pretoria, Repubilek van Suid-Afrika.
Abstract:
The results of a study conducted to determine the clinico-pathological changes in 4 experimentally-induced cases of endotoxaemia in the horse are reported on. Endotoxaemia was induced by injecting commercially available E. coli 055:B5 lipopolysaccharide intravenously at a dose of 1 microgram kg-1. The haematocrit, red cell count, total and differential white cell counts, thrombocyte count, prothrombin time, partial thromboplastin time, fibrinogen level, level of fibrin degradation products, arterial acid-base status, serum lactate and blood glucose were determined repeatedly. Changes that occurred, include increases in the haematocrit and red cell count, a leucopaenia followed by a leucocytosis caused mainly by changes in the number of neutrophils, the development of disseminated intravascular coagulation, minor changes in the arterial acid base parameters, hyperglycaemia followed by hypoglycaemia and an increase in serum lactate.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Acute Inflammation III: Local and Systemic Effects
Acute Pancreatitis II: Pathophysiology

